ETF Daily News1mon
Critical Survey: Vivos Therapeutics (NASDAQ:VVOS) & Iradimed (NASDAQ:IRMD)
26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 92.3% of Iradimed shares are owned by institutional investors. 9.6% of Vivos Therapeutics shares are ...
Mena FN1mon
Investornewsbreaks Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage For Vivos CARE Oral Medical Devices
(MENAFN- Investor Brand Network) Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company specializing in the development and commercialization of highly effective proprietary treatments ...
Yahoo Finance1mon
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
LITTLETON, Colo., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company ...
Investing1mon
Vivos Therapeutics Inc (VVOS)
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Oil & Gas, Technology and Basic Materials sectors led shares higher. At the close in NYSE, the ...
Mena FN1mon
Tinygemsbreaks Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces $4.3M Registered Direct Offering
(MENAFN- Investor Brand Network) Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective ...
ADVFN1mon
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...